ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide

INTRODUCTION: Dulaglutide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), became available in Italy in April 2016. The aim of ANDREW (Active Notes on Dulaglutide in the REal World), a multicenter, prospective, observational study, was to evaluate glycemic control and weight (co-pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossi, Antonio C., De Mori, Valentina, Scaranna, Cristiana, Veronesi, Giovanni, Lepore, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547933/
https://www.ncbi.nlm.nih.gov/pubmed/32974879
http://dx.doi.org/10.1007/s13300-020-00929-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547933/
https://www.ncbi.nlm.nih.gov/pubmed/32974879
http://dx.doi.org/10.1007/s13300-020-00929-4

Ejemplares similares